Literature DB >> 32240774

End-of-Range Radiobiological Effect on Rib Fractures in Patients Receiving Proton Therapy for Breast Cancer.

Chia-Chun Wang1, Aimee L McNamara2, Jungwook Shin2, Jan Schuemann2, Clemens Grassberger2, Alphonse G Taghian2, Rachel B Jimenez2, Shannon M MacDonald2, Harald Paganetti3.   

Abstract

PURPOSE: A prospective trial of proton therapy for breast cancer revealed an increased rib fracture rate of 7%, which is higher than the expected rate based on the literature on photon therapies. We aim to evaluate the hypothesis that the increased relative biological effectiveness (RBE) at the distal edge of proton beams is the cause. METHODS AND MATERIALS: We combined the cohort from the prospective clinical trial and a retrospective cohort from a database. Monte Carlo simulations were performed to recalculate the physical dose and dose-averaged linear energy transfer (LETd). The first 10 ribs and fracture areas in patients with fractures were contoured and deformably registered. The LETd-weighted dose was used as a surrogate for biological effectiveness and compared with the conventional fixed RBE of 1.1. Dose to 0.5 cm3 of the ribs (D0.5) was selected to analyze the dose-response relationship using logistic regression. We chose an alpha/beta ratio of 3 to calculate the biological effective dose in Gy3(RBE).
RESULTS: Thirteen of 203 patients in the cohorts exhibited a total of 25 fractures. The LETd in fractured areas is increased (6.1 ± 2.0 keV/μm, mean ± standard deviation), suggesting possible end-of-range radiobiological effects with increased RBE. The D0.5 of the fractured ribs is 80.3 ± 9.4 Gy3(RBE) with a generic factor of 1.1 and is relatively low compared with historical photon results. On the other hand, the D0.5 of the fractured ribs is 100.0 ± 12.5 Gy3(RBE) using the LETd-based model with a dose-response curve that is more consistent with historical photon data.
CONCLUSIONS: The increased rib fracture rate seen in our trial is probably associated with the increased LETd and RBE at the distal edge of proton beams. This phenomenon warrants further investigation and possible integration of LETd into treatment planning and optimization in proton therapy.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32240774      PMCID: PMC7293563          DOI: 10.1016/j.ijrobp.2020.03.012

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  26 in total

1.  LET-weighted doses effectively reduce biological variability in proton radiotherapy planning.

Authors:  Stephen J McMahon; Harald Paganetti; Kevin M Prise
Journal:  Phys Med Biol       Date:  2018-11-09       Impact factor: 3.609

2.  Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship.

Authors:  Kaori Asai; Yoshiyuki Shioyama; Katsumasa Nakamura; Tomonari Sasaki; Saiji Ohga; Takeshi Nonoshita; Tadamasa Yoshitake; Kayoko Ohnishi; Kotaro Terashima; Keiji Matsumoto; Hideki Hirata; Hiroshi Honda
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-23       Impact factor: 7.038

3.  Phase II Study of Proton Beam Radiation Therapy for Patients With Breast Cancer Requiring Regional Nodal Irradiation.

Authors:  Rachel B Jimenez; Shea Hickey; Nicolas DePauw; Beow Y Yeap; Estelle Batin; Michelle A Gadd; Michelle Specht; Steven J Isakoff; Barbara L Smith; Eric C Liao; Amy S Colwell; Alice Ho; James L Januzzi; Jonathan Passeri; Tomas G Neilan; Alphonse G Taghian; Hsiao-Ming Lu; Shannon M MacDonald
Journal:  J Clin Oncol       Date:  2019-08-26       Impact factor: 44.544

4.  Dosemetric Parameters Predictive of Rib Fractures after Proton Beam Therapy for Early-Stage Lung Cancer.

Authors:  Yojiro Ishikawa; Tatsuya Nakamura; Takahiro Kato; Noriyuki Kadoya; Motohisa Suzuki; Yusuke Azami; Masato Hareyama; Yasuhiro Kikuchi; Keiichi Jingu
Journal:  Tohoku J Exp Med       Date:  2016-04       Impact factor: 1.848

5.  Contemporary Toxicity Profile of Breast Brachytherapy Versus External Beam Radiation After Lumpectomy for Breast Cancer.

Authors:  Jinhai Huo; Sharon H Giordano; Benjamin D Smith; Simona F Shaitelman; Grace L Smith
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-12-17       Impact factor: 7.038

Review 6.  Clinical Outcomes and Toxicity of Proton Radiotherapy for Breast Cancer.

Authors:  Vivek Verma; Chirag Shah; Minesh P Mehta
Journal:  Clin Breast Cancer       Date:  2016-02-12       Impact factor: 3.225

7.  Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.

Authors:  Ayae Kanemoto; Masashi Mizumoto; Toshiyuki Okumura; Hideto Takahashi; Takayuki Hashimoto; Yoshiko Oshiro; Nobuyoshi Fukumitsu; Takashi Moritake; Koji Tsuboi; Takeji Sakae; Hideyuki Sakurai
Journal:  Acta Oncol       Date:  2012-09-05       Impact factor: 4.089

8.  Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for Stage I primary lung cancer.

Authors:  Hideharu Miura; Toshihiko Inoue; Hiroya Shiomi; Ryoong-Jin Oh
Journal:  J Radiat Res       Date:  2014-12-11       Impact factor: 2.724

9.  Clinical outcomes and toxicity of proton beam radiation therapy for re-irradiation of locally recurrent breast cancer.

Authors:  Prashant Gabani; Hetal Patel; Maria A Thomas; Beth Bottani; S Murty Goddu; William Straube; Julie A Margenthaler; Laura Ochoa; Jeff D Bradley; Imran Zoberi
Journal:  Clin Transl Radiat Oncol       Date:  2019-10-02

10.  Predictors of radiotherapy induced bone injury (RIBI) after stereotactic lung radiotherapy.

Authors:  Mojgan Taremi; Andrew Hope; Patricia Lindsay; Max Dahele; Sharon Fung; Thomas G Purdie; David Jaffray; Laura Dawson; Andrea Bezjak
Journal:  Radiat Oncol       Date:  2012-09-17       Impact factor: 3.481

View more
  10 in total

Review 1.  Mechanisms and Review of Clinical Evidence of Variations in Relative Biological Effectiveness in Proton Therapy.

Authors:  Harald Paganetti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-08-15       Impact factor: 8.013

2.  Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.

Authors:  Christian Hahn; Lena Heuchel; Jakob Ödén; Erik Traneus; Jörg Wulff; Sandija Plaude; Beate Timmermann; Christian Bäumer; Armin Lühr
Journal:  Radiat Oncol       Date:  2022-10-22       Impact factor: 4.309

3.  The Organ Sparing Potential of Different Biological Optimization Strategies in Proton Therapy.

Authors:  Helge Henjum; Tordis J Dahle; Lars Fredrik Fjæra; Eivind Rørvik; Sara Pilskog; Camilla H Stokkevåg; Andrea Mairani; Kristian S Ytre-Hauge
Journal:  Adv Radiat Oncol       Date:  2021-08-17

Review 4.  Flourish of Proton and Carbon Ion Radiotherapy in China.

Authors:  Yue Li; Xiaoman Li; Jiancheng Yang; Sicheng Wang; Meitang Tang; Jiawen Xia; Yunzhe Gao
Journal:  Front Oncol       Date:  2022-02-14       Impact factor: 6.244

Review 5.  Particle Therapy for Breast Cancer.

Authors:  Roman O Kowalchuk; Kimberly S Corbin; Rachel B Jimenez
Journal:  Cancers (Basel)       Date:  2022-02-20       Impact factor: 6.639

6.  Radiation-Induced Toxicity Risks in Photon Versus Proton Therapy for Synchronous Bilateral Breast Cancer.

Authors:  Line Bjerregaard Stick; Maria Fuglsang Jensen; Søren M Bentzen; Claus Kamby; Anni Young Lundgaard; Maja Vestmø Maraldo; Birgitte Vrou Offersen; Jen Yu; Ivan Richter Vogelius
Journal:  Int J Part Ther       Date:  2021-11-11

Review 7.  Heart Sparing Radiotherapy Techniques in Breast Cancer: A Focus on Deep Inspiration Breath Hold.

Authors:  Hayley B Stowe; Neal D Andruska; Francisco Reynoso; Maria Thomas; Carmen Bergom
Journal:  Breast Cancer (Dove Med Press)       Date:  2022-07-20

Review 8.  Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee.

Authors:  Robert W Mutter; J Isabelle Choi; Rachel B Jimenez; Youlia M Kirova; Marcio Fagundes; Bruce G Haffty; Richard A Amos; Julie A Bradley; Peter Y Chen; Xuanfeng Ding; Antoinette M Carr; Leslie M Taylor; Mark Pankuch; Raymond B Mailhot Vega; Alice Y Ho; Petra Witt Nyström; Lisa A McGee; James J Urbanic; Oren Cahlon; John H Maduro; Shannon M MacDonald
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-05-25       Impact factor: 8.013

Review 9.  Roadmap: proton therapy physics and biology.

Authors:  Harald Paganetti; Chris Beltran; Stefan Both; Lei Dong; Jacob Flanz; Keith Furutani; Clemens Grassberger; David R Grosshans; Antje-Christin Knopf; Johannes A Langendijk; Hakan Nystrom; Katia Parodi; Bas W Raaymakers; Christian Richter; Gabriel O Sawakuchi; Marco Schippers; Simona F Shaitelman; B K Kevin Teo; Jan Unkelbach; Patrick Wohlfahrt; Tony Lomax
Journal:  Phys Med Biol       Date:  2021-02-26       Impact factor: 4.174

10.  RBE-weighted dose and its impact on the risk of acute coronary event for breast cancer patients treated with intensity modulated proton therapy.

Authors:  Chunbo Liu; Julie A Bradley; Dandan Zheng; Raymond B Mailhot Vega; Chris J Beltran; Nancy Mendenhall; Xiaoying Liang
Journal:  J Appl Clin Med Phys       Date:  2022-01-21       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.